<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">330732</id>
  <title nil="true"/>
  <common-name>6-imino-11-methyl-2-oxo-7-prop-2-enyl-n-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide</common-name>
  <description>6-imino-11-methyl-2-oxo-7-prop-2-enyl-n-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide is a chemical compound with the formula C22H20N6O2. It has an average molecular weight of 400.40 g/mol.</description>
  <cas>510761-30-5</cas>
  <pubchem-id>1077386</pubchem-id>
  <chemical-formula>C22H20N6O2</chemical-formula>
  <weight>400.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T11:23:54Z</created-at>
  <updated-at type="dateTime">2026-08-30T11:23:54Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CC=C)C(=O)NCC4=CN=CC=C4</moldb-smiles>
  <moldb-formula>C22H20N6O2</moldb-formula>
  <moldb-inchi>InChI=1S/C22H20N6O2/c1-3-9-27-18(23)16(21(29)25-13-15-7-4-8-24-12-15)11-17-20(27)26-19-14(2)6-5-10-28(19)22(17)30/h3-8,10-12,23H,1,9,13H2,2H3,(H,25,29)</moldb-inchi>
  <moldb-inchikey>WPBZLQRKBPCAHU-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">400.1647739</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM326625</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>6-imino-11-methyl-2-oxo-7-prop-2-enyl-n-(pyridin-3-ylmethyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaene-5-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridopyrimidines</klass>
  <subklass>Pyrido[2,3-d]pyrimidines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0281278</sync-id>
  <structure-inchikey>WPBZLQRKBPCAHU-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>1000800100000000000000000000000004000000000000010000000000000020000000000000002000000000000004000000000002000080000000000400000010000080000140000420000000000200000000000000000000000000210400080000000000100000000000000108000000000000000100004000100040200000800400000004000080000000000000000000000000000000000000000400000000048200080100000000000000000000000000010000000100100000040020001000800000040000000000108000002000000220000000000000010800000001202040000080000400000000000040000101000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAeAAAAIQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:33:13Z</structure-indexed-at>
</compound>
